These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28101958)

  • 1. A review of maternal alloimmunisation to Rh D in Northern Ireland.
    McCauley CJ; Morris K; Maguire K
    Transfus Med; 2017 Apr; 27(2):132-135. PubMed ID: 28101958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of maternal sensitisation to Rh(D) in Christchurch, New Zealand and reasons for prophylaxis failures.
    Badami KG; Parker J; Kenny A; Warrington S
    N Z Med J; 2014 Jan; 127(1388):40-6. PubMed ID: 24481385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical validation of routine antenatal anti-D prophylaxis questions the modelling predictions adopted by NICE for Rhesus D sensitisation rates: results of a longitudinal study.
    Mackenzie IZ; Roseman F; Findlay J; Thompson K; McPherson K
    Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):38-42. PubMed ID: 18243487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fetal and neonatal outcomes of Rhesus D antibody affected pregnancies in Northern Ireland.
    Craig S; Morris K; Tubman T; McClure B
    Ir Med J; 2000; 93(1):17-8. PubMed ID: 10740367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The scientific basis of antenatal prophylaxis.
    Urbaniak SJ
    Br J Obstet Gynaecol; 1998 Nov; 105 Suppl 18():11-8. PubMed ID: 9863973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    Crowther CA; Middleton P; McBain RD
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
    MacKenzie IZ; Findlay J; Thompson K; Roseman F
    BJOG; 2006 Jul; 113(7):839-43. PubMed ID: 16827770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An audit of anti-D sensitisation in Yorkshire.
    McSweeney E; Kirkham J; Vinall P; Flanagan P
    Br J Obstet Gynaecol; 1998 Oct; 105(10):1091-4. PubMed ID: 9800932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhesus Negative Woman Transfused With Rhesus Positive Blood: Subsequent Normal Pregnancy Without Anti D production.
    Maya ET; Buntugu KA; Pobee F; Srofenyoh EK
    Ghana Med J; 2015 Mar; 49(1):60-3. PubMed ID: 26339087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-D administration in pregnancy for preventing rhesus alloimmunisation.
    Crowther CA; Keirse MJ
    Cochrane Database Syst Rev; 2000; (2):CD000020. PubMed ID: 10796088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal red blood cell alloimmunisation in south western Uganda.
    Natukunda B; Mugyenyi G; Brand A; Schonewille H
    Transfus Med; 2011 Aug; 21(4):262-6. PubMed ID: 21371143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compliance with postpartum Rh isoimmunization prophylaxis in Alberta.
    Huchcroft S; Gunton P; Bowen T
    CMAJ; 1985 Nov; 133(9):871-5. PubMed ID: 2996738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal prophylaxis of Rh immunization with 250 micrograms anti-D immunoglobulin.
    Hermann M; Kjellman H; Ljunggren C
    Acta Obstet Gynecol Scand Suppl; 1984; 124():1-15. PubMed ID: 6095582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-D human immunoglobulin: new preparation. Important in young Rh D (-) women.
    Prescrire Int; 2001 Feb; 10(51):4-7. PubMed ID: 11503859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing Rhesus D haemolytic disease of the newborn by giving anti-D immunoglobulin: are the guidelines being adequately followed?
    Howard HL; Martlew VJ; McFadyen IR; Clarke CA
    Br J Obstet Gynaecol; 1997 Jan; 104(1):37-41. PubMed ID: 8988694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-D in Rh(D)-negative pregnant women: are at-risk pregnancies and deliveries receiving appropriate prophylaxis?
    Koby L; Grunbaum A; Benjamin A; Koby R; Abenhaim HA
    J Obstet Gynaecol Can; 2012 May; 34(5):429-435. PubMed ID: 22555135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-D administration after childbirth for preventing Rhesus alloimmunisation.
    Crowther C; Middleton P
    Cochrane Database Syst Rev; 2000; 1997(2):CD000021. PubMed ID: 10796089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time points and risk factors for RhD immunizations after the implementation of targeted routine antenatal anti-D prophylaxis: A retrospective nationwide cohort study.
    Jernman R; Isaksson C; Haimila K; Kuosmanen M; Mäkikallio-Anttila K; Toivonen S; Ordén MR; Sulin K; Tihtonen K; Vääräsmäki M; Sainio S
    Acta Obstet Gynecol Scand; 2021 Oct; 100(10):1868-1875. PubMed ID: 34157128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.